Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Tulasigeri Totiger

6PUBLICATIONS
86CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursCancer geneticsMolecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Nov 24, 2025
Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AML.

Mina M Tayari, Helena Gomes Dos Santos, Felipe Beckedorff

|Jul 30, 2025
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53-mutated myeloid malignancies.

Traci L Kruer, Ariel Quintana, Hannah Newman

|Jun 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance.

Tulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca

|Feb 01, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Skye Montoya, Jessie Bourcier, Mark Noviski

|Feb 25, 2023
Targeted Therapy Development in Acute Myeloid Leukemia.

Tulasigeri M Totiger, Anirban Ghoshal, Jenna Zabroski

|Jan 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.

Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan

Pageof 1

Frequent Collaborators

6 joint publications

Justin Taylor

4 joint publications

Jacob Jahn

2 joint publications

Rajesh Kumar Soni

2 joint publications

Efe Karaca

2 joint publications

Maurizio Affer

2 joint publications

Daniel Bilbao

2 joint publications

Ryan Q Notti

2 joint publications

Skye Montoya

1 joint publications

Ramin Shiekhattar

1 joint publications

Juan Arango Ossa

Frequent Collaborators

6 joint publications

Justin Taylor

4 joint publications

Jacob Jahn

2 joint publications

Rajesh Kumar Soni

2 joint publications

Efe Karaca

Top Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

8.6K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos

Top Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

8.6K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
See more related videos